285 related articles for article (PubMed ID: 18290729)
1. Targets of vitamin D receptor signaling in the mammary gland.
Welsh J
J Bone Miner Res; 2007 Dec; 22 Suppl 2():V86-90. PubMed ID: 18290729
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D and prevention of breast cancer.
Welsh J
Acta Pharmacol Sin; 2007 Sep; 28(9):1373-82. PubMed ID: 17723171
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D metabolism in mammary gland and breast cancer.
Welsh J
Mol Cell Endocrinol; 2011 Dec; 347(1-2):55-60. PubMed ID: 21669251
[TBL] [Abstract][Full Text] [Related]
4. Autocrine TGFbeta signaling mediates vitamin D3 analog-induced growth inhibition in breast cells.
Yang L; Yang J; Venkateswarlu S; Ko T; Brattain MG
J Cell Physiol; 2001 Sep; 188(3):383-93. PubMed ID: 11473365
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel mediators of Vitamin D signaling and 1,25(OH)2D3 resistance in mammary cells.
Byrne B; Welsh J
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):703-7. PubMed ID: 17254776
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer cell regulation by high-dose Vitamin D compounds in the absence of nuclear vitamin D receptor.
Valrance ME; Welsh J
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):221-5. PubMed ID: 15225775
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice.
Zinser GM; Welsh J
Carcinogenesis; 2004 Dec; 25(12):2361-72. PubMed ID: 15333467
[TBL] [Abstract][Full Text] [Related]
8. Function of the vitamin D endocrine system in mammary gland and breast cancer.
Welsh J
Mol Cell Endocrinol; 2017 Sep; 453():88-95. PubMed ID: 28579119
[TBL] [Abstract][Full Text] [Related]
9. The vitamin D receptor in cancer.
Thorne J; Campbell MJ
Proc Nutr Soc; 2008 May; 67(2):115-27. PubMed ID: 18412986
[TBL] [Abstract][Full Text] [Related]
10. 1 alpha,25-Dihydroxyvitamin D(3) is a preventive factor in the metastasis of lung cancer.
Nakagawa K; Kawaura A; Kato S; Takeda E; Okano T
Carcinogenesis; 2005 Feb; 26(2):429-40. PubMed ID: 15539405
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of ER and VDR is not sufficient to make ER-negative MDA-MB231 breast cancer cells responsive to 1alpha-hydroxyvitamin D5.
Peng X; Jhaveri P; Hussain-Hakimjee EA; Mehta RG
Carcinogenesis; 2007 May; 28(5):1000-7. PubMed ID: 17130524
[TBL] [Abstract][Full Text] [Related]
12. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
Gilad LA; Bresler T; Gnainsky J; Smirnoff P; Schwartz B
J Endocrinol; 2005 Jun; 185(3):577-92. PubMed ID: 15930183
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D receptor modulates the neoplastic phenotype through antagonistic growth regulatory signals.
Xu H; McCann M; Zhang Z; Posner GH; Bingham V; El-Tanani M; Campbell FC
Mol Carcinog; 2009 Aug; 48(8):758-72. PubMed ID: 19184984
[TBL] [Abstract][Full Text] [Related]
14. Effects of continuous activation of vitamin D and Wnt response pathways on osteoblastic proliferation and differentiation.
Shi YC; Worton L; Esteban L; Baldock P; Fong C; Eisman JA; Gardiner EM
Bone; 2007 Jul; 41(1):87-96. PubMed ID: 17513186
[TBL] [Abstract][Full Text] [Related]
15. Stable expression of human VDR in murine VDR-null cells recapitulates vitamin D mediated anti-cancer signaling.
Keith ME; LaPorta E; Welsh J
Mol Carcinog; 2014 Apr; 53(4):286-99. PubMed ID: 23681781
[TBL] [Abstract][Full Text] [Related]
16. Mammary adipocytes bioactivate 25-hydroxyvitamin D₃ and signal via vitamin D₃ receptor, modulating mammary epithelial cell growth.
Ching S; Kashinkunti S; Niehaus MD; Zinser GM
J Cell Biochem; 2011 Nov; 112(11):3393-405. PubMed ID: 21769914
[TBL] [Abstract][Full Text] [Related]
17. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
18. Wnt signaling pathway in mammary gland development and carcinogenesis.
Turashvili G; Bouchal J; Burkadze G; Kolar Z
Pathobiology; 2006; 73(5):213-23. PubMed ID: 17314492
[TBL] [Abstract][Full Text] [Related]
19. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.
Boehm MF; Fitzgerald P; Zou A; Elgort MG; Bischoff ED; Mere L; Mais DE; Bissonnette RP; Heyman RA; Nadzan AM; Reichman M; Allegretto EA
Chem Biol; 1999 May; 6(5):265-75. PubMed ID: 10322128
[TBL] [Abstract][Full Text] [Related]
20. Functions of 1alpha,25-dihydroxyvitamin D(3) in mammary gland: from normal development to breast cancer.
Narvaez CJ; Zinser G; Welsh J
Steroids; 2001; 66(3-5):301-8. PubMed ID: 11179738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
